Actively Recruiting
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Led by Sonoma Biotherapeutics, Inc. · Updated on 2026-04-16
36
Participants Needed
10
Research Sites
801 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.
CONDITIONS
Official Title
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject was previously administered at least 1 dose of a Sonoma Biotherapeutics, Inc. gene-modified Treg therapeutic in a prior parent treatment protocol.
- Subject understands the purpose and risks of the study and is willing to provide written informed consent.
- Subject is willing to comply with all study procedures for the follow-up period.
You will not qualify if you...
- Participation in the study is not in the subject's best interest, in the opinion of the Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
UCSF Medical Center
San Francisco, California, United States, 94143
Actively Recruiting
2
Stanford Medical Center
Stanford, California, United States, 94305
Actively Recruiting
3
University of Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
4
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
5
Tufts University
Boston, Massachusetts, United States, 02111
Actively Recruiting
6
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
7
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
8
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Not Yet Recruiting
9
Duke University
Durham, North Carolina, United States, 27708
Not Yet Recruiting
10
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Not Yet Recruiting
Research Team
S
Sabrina Fox-Bosetti, MPH
CONTACT
J
Jason Do
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here